Turalio BPA base year with four one-year option periods
Ended Awarded Last action
- Contract number
- 36E79720A0012
- Awardee
-
Daiichi Sankyo, Inc. UEI YUKQY5G72Q29
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $1,378,620.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The U.S. Department of Veterans Affairs (VA) awarded Daiichi Sankyo, Inc. a single-award Blanket Purchase Agreement (BPA) under the GSA Pharmaceuticals and Drugs Schedule. The BPA has a ceiling value of $1,378,620 and a period of performance from May 22, 2020 to May 21, 2025. The purpose of this contract is to provide the VA healthcare system with a stable supply of the specialty pharmaceutical product pexidartinib, marketed under the brand name TURALIO, for the treatment of tenosynovial giant cell tumor in eligible veteran patients.
The BPA structure, with a base year and four one-year option periods, enables VA facilities nationwide to efficiently place delivery orders for the drug as needed. Previous federal contract awards to Daiichi Sankyo have involved the supply of TURALIO capsules in various dosage forms, primarily 125mg, to VA medical centers across the United States. These firm fixed-price delivery orders, typically ranging from $7,500 to $73,650 with delivery timelines of several months to a year, have been awarded without any socioeconomic set-asides, indicating Daiichi Sankyo's competitiveness in the unrestricted federal pharmaceutical marketplace.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79720A0012?
36E79720A0012 was awarded to Daiichi Sankyo, Inc. by National Acquisition Center (Headquarters) on May 22, 2020.
How much is contract 36E79720A0012 worth?
36E79720A0012's own ceiling is $1,378,620.
Who can order from contract 36E79720A0012?
36E79720A0012 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79720A0012 under another contract?
Yes. 36E79720A0012 is a blanket purchase agreement under 36F79718D0403, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79720A0012 competed?
The extent of competition for 36E79720A0012 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV